影像组学预测胆道恶性肿瘤门静脉栓塞术后未来肝剩余增生:一项回顾性队列研究
本研究纳入43例因胆道恶性肿瘤行门静脉栓塞术的患者,基于术前CT进行肝脏纹理分析并结合临床及实验室参数,预测未来肝剩余增生程度。结果显示血清碱性磷酸酶(p=0.014)和天冬氨酸转氨酶(p=0.021)在增生<25%组与≥25%组间有显著差异,肝段1和3的峰度值及段6的偏度值在部分空间尺度滤波器下组间差异显著,ROC曲线下面积为0.66至0.76。作者认为术前CT影像组学有潜力预测门静脉栓塞术后未来肝剩余增生,可能有助于患者分层。
要点
- 术前CT肝脏纹理分析可预测门静脉栓塞术后未来肝剩余增生,ROC曲线下面积为0.66至0.76。
- 增生<25%组与≥25%组间血清碱性磷酸酶(p=0.014)和天冬氨酸转氨酶(p=0.021)有显著差异。
- 肝段1和3的峰度值在多个空间尺度滤波器下组间差异显著,段6偏度在空间尺度滤波器5下差异显著。
核心结论
- 术前CT肝脏影像组学有潜力预测胆道恶性肿瘤门静脉栓塞术后未来肝剩余增生,可能成为患者分层的有前景工具。
研究设计与样本
- 回顾性队列研究,纳入43例(平均年龄46.8岁;男25例,女18例)在本机构因胆道恶性肿瘤行门静脉栓塞术的患者,收集临床、生化和影像数据,对术前CT扫描进行纹理分析。
关键影像表现/征象
- 肝段1和3的峰度值在多个空间尺度滤波器下组间差异显著(p<0.05)。
- 肝段6的偏度值在空间尺度滤波器5下组间差异显著。
诊断标准与关键数值
- 以门静脉栓塞术后未来肝剩余体积占全肝体积百分比分组:A组<25%增生,B组≥25%增生。
- 血清碱性磷酸酶组间差异p=0.014。
- 血清天冬氨酸转氨酶组间差异p=0.021。
- 上述参数的ROC曲线下面积为0.66至0.76。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Portal vein embolization (PVE) is an established procedure to induce hypertrophy of the future liver remnant (FLR) in cases requiring major hepatectomies. However, prediction of FLR hypertrophy prior to PVE is challenging. The study aims to evaluate the utility of CT derived radiomics of the liver and clinical and laboratory parameters in predicting the hypertrophy of FLR.
METHODS: This retrospective cohort study included 43 patients (mean age 46.8 years; males - 25; females - 18) who underwent PVE for biliary malignancies at our institution. Clinical, biochemical, and imaging data were collected, and texture analysis was performed on pre-PVE CT scans. Patients were stratified into two groups based on post-PVE FLR volume as a percentage of total liver volume (Group A < 25% hypertrophy, Group B ≥ 25% hypertrophy), and comparisons were made between biochemical parameters and texture analysis findings.
RESULTS: There were 18 patients (mean age: 47.3 years; 12 males) in group A and 25 patients (mean age: 47.9 years; 13 males) in group B. Significant differences were seen in serum alkaline phosphatase (p = 0.014) and serum aspartate transaminase (p = 0.021) levels between the two groups. Significant differences (p < 0.05) were observed in the kurtosis values of liver segments 1 and 3 between the two groups at multiple spatial scale filters (SSF). Additionally, segment 6 showed a significant difference in skewness at SSF 5. ROC curve analysis revealed area under the curves ranging from 0.66 to 0.76 for the above mentioned parameters.
CONCLUSION: Pre-procedure CT radiomics of the liver has the ability to predict FLR hypertrophy after PVE in biliary malignancies and could be a promising tool in patient stratification.
引用
- Aggarwal P, Pandey S, Madhusudhan KS, et al. Exploring radiomics as a predictor of hypertrophy of future liver remnant after portal vein embolization in biliary malignancies: a retrospective cohort study. Abdom Radiol (NY). 2025. PMID: 40627134. doi:10.1007/s00261-025-05117-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。